EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access

Long-term safety and efficacy of intracortical microstimulation in humans

Charles M Greenspon iD, Taylor G Hobbs iD, Ceci Verbaarschot iD, Ali H Alamri iD, Natalya D Shelchkova iD, Robin Lienkämper iD, Joel Ye iD, Tyler W Simpson iD, Jeffrey M Weiss iD, David M Weir iD, Debbie E Harrington iD, Ashley Van Driesche und 10 weitere

Science Translational Medicine · 15.07.2026 · 18 (858)

DOI: 10.1126/scitranslmed.aec3728 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Science Translational Medicine, erschienen am 15.07.2026. Verfasst von Charles M Greenspon und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organismal Biology and Anatomy, University of Chicago, Chicago, IL, USA. Hauptthemen laut MEDLINE: Electric Stimulation Therapy, Somatosensory Cortex. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke, Defense Advanced Research Projects Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intracortical microstimulation (ICMS) of somatosensory cortex can restore a sense of touch to people with spinal cord injury. In this early feasibility clinical trial (NCT01894802), we evaluated the safety, efficacy, and longevity of ICMS because there is a paucity of such long-term studies in humans. This information is crucial to the development of clinical neuromodulation devices, particularly for restoring touch, hearing, and vision. ICMS was delivered to five participants with spinal cord injury who were each implanted with two Blackrock NeuroPort microelectrode arrays in the hand representation of Brodmann’s area 1. Across implant durations spanning 2 to 10 years, we measured single-electrode detection thresholds, projected fields, quality reports, and electrode health characteristics. ICMS-related adverse events were documented throughout. More than 168 million ICMS pulses were delivered across a combined implant duration of 27 years without any serious adverse events or direct negative effects on electrode health. ICMS consistently evoked sensations localized to the hand. Rarely, sensations persisted for brief periods after stimulation offset (3 to 25 events across participants). ICMS detection thresholds increased slowly over time (about 3.5 microamperes per year), but 64 ± 13% of the electrodes still reliably evoked tactile sensations (about 21% decrease in functional electrodes), including 60% of the electrodes after 10 years in one participant. The quality and projected field coverage of ICMS-evoked sensations were both consistent. Delivering ICMS to the somatosensory cortex was safe and effective, consistently evoking informative somatosensory percepts as long as 10 years, demonstrating the clinical promise of ICMS for sensory restoration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electric Stimulation TherapySomatosensory CortexAdultFemaleHumansMaleMiddle AgedElectrodes, ImplantedMicroelectrodesSpinal Cord InjuriesTime Factors

Autor:innen und Institutionen

  • Department of Organismal Biology and Anatomy, University of Chicago, Chicago, IL, USA.
  • Department of Neurological Surgery, University of Chicago, Chicago, IL, USA.
  • Rehab Neural Engineering Labs, University of Pittsburgh, Pittsburgh, PA, USA.
  • Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA.
  • Department of Neurological Surgery, University of Texas-Southwestern, Dallas, TX, USA.
  • Department of Biomedical Engineering, University of Texas-Southwestern, Dallas, TX, USA.

ORCID-Profile: Charles M Greenspon, Taylor G Hobbs, Ceci Verbaarschot, Ali H Alamri, Natalya D Shelchkova, Robin Lienkämper, Joel Ye, Tyler W Simpson, Jeffrey M Weiss, David M Weir, Debbie E Harrington, Giacomo Valle, Lee E Miller, Nicholas G Hatsopoulos, Jorge Gonzalez-Martinez, John E Downey, Michael L Boninger, Jennifer L Collinger, Robert A Gaunt

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • Defense Advanced Research Projects Agency

Zitieren

APA

Greenspon, C. M., Hobbs, T. G., Verbaarschot, C., Alamri, A. H., Shelchkova, N. D., Lienkämper, R., Ye, J., Simpson, T. W., Weiss, J. M., Weir, D. M., Harrington, D. E., Van Driesche, A., Satzer, D., Valle, G., Miller, L. E., Hatsopoulos, N. G., Gonzalez-Martinez, J., Warnke, P. C., Downey, J. E., …, & Gaunt, R. A. (2026). Long-term safety and efficacy of intracortical microstimulation in humans. Science Translational Medicine, 18(858). https://doi.org/10.1126/scitranslmed.aec3728

Vancouver

Greenspon CM, Hobbs TG, Verbaarschot C, Alamri AH, Shelchkova ND, Lienkämper R, et al. Long-term safety and efficacy of intracortical microstimulation in humans. Science Translational Medicine. 2026;18(858). doi:10.1126/scitranslmed.aec3728

BibTeX
@article{Greenspon2026,
  author = {Greenspon, Charles M and Hobbs, Taylor G and Verbaarschot, Ceci and Alamri, Ali H and Shelchkova, Natalya D and Lienkämper, Robin and Ye, Joel and Simpson, Tyler W and Weiss, Jeffrey M and Weir, David M and Harrington, Debbie E and Van Driesche, Ashley and Satzer, David and Valle, Giacomo and Miller, Lee E and Hatsopoulos, Nicholas G and Gonzalez-Martinez, Jorge and Warnke, Peter C and Downey, John E and Boninger, Michael L and Collinger, Jennifer L and Gaunt, Robert A},
  title = {Long-term safety and efficacy of intracortical microstimulation in humans},
  journal = {Science Translational Medicine},
  year = {2026},
  volume = {18},
  number = {858},
  doi = {10.1126/scitranslmed.aec3728}
}
Kostenlos starten →